Biomedical and Pharmacological Uses of Fluorescein Isothiocyanate Chitosan-Based Nanocarriers

Macromol Biosci. 2021 Jan;21(1):e2000312. doi: 10.1002/mabi.202000312. Epub 2020 Oct 4.

Abstract

Chitosan-based nanocarriers (ChNCs) are considered suitable drug carriers due to their ability to encapsulate a variety of drugs and cross biological barriers to deliver the cargo to their target site. Fluorescein isothiocyanate-labeled chitosan-based NCs (FITC@ChNCs) are used extensively in biomedical and pharmacological applications. The main advantage of using FITC@ChNCs consists of the ability to track their fate both intra and extracellularly. This journey is strictly dependent on the physico-chemical properties of the carrier and the cell types under investigation. Other applications make use of fluorescent ChNCs in cell labeling for the detection of disorders in vivo and controlling of living cells in situ. This review describes the use of FITC@ChNCs in the various applications with a focus on understanding their usefulness in labeled drug-delivery systems.

Keywords: cellular imaging; cellular uptake; chitosan nanocarriers; fluorescein isothiocyanate; targeted drug delivery.

Publication types

  • Review

MeSH terms

  • Chitosan / chemistry
  • Chitosan / therapeutic use*
  • Drug Carriers / chemistry*
  • Drug Carriers / therapeutic use
  • Drug Delivery Systems*
  • Fluorescein-5-isothiocyanate / chemistry
  • Fluorescein-5-isothiocyanate / therapeutic use
  • Humans
  • Nanoparticles / chemistry*

Substances

  • Drug Carriers
  • Chitosan
  • Fluorescein-5-isothiocyanate